Avalglucosidase alfa

Therapeutic indications

Avalglucosidase alfa is indicated for:

Pompe disease

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

Avalglucosidase alfa is indicated for long-term enzyme replacement therapy for the treatment of patients with Pompe disease (acid α-glucosidase deficiency).

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 20 mg/kg once every 2 weeks

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines